Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human haemopoietic stem cell assays

M Y Gordon1

  • 1Leukaemia Research Fund Centre, Institute of Cancer Research, London, UK.

Blood Reviews
|September 1, 1993
PubMed
Summary
This summary is machine-generated.

Developing reliable assays for human hematopoietic stem cells (HSCs) is crucial for understanding blood production. Current methods, including in vitro and in vivo models, aim to quantify and identify these vital cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease.

Cell proliferation·2008
Same author

Subcellular distribution of p210(BCR-ABL) in CML cell lines and primary CD34+ CML cells.

Leukemia·2007
Same author

Stem cells as a treatment for chronic liver disease and diabetes.

Handbook of experimental pharmacology·2007
Same author

Clinical applications of stem cell therapy--the pros and cons of stem cell sources.

Regenerative medicine·2007
Same author

Phosphatidylinositol-3 kinase inhibitors reproduce the selective antiproliferative effects of imatinib on chronic myeloid leukaemia progenitor cells.

British journal of haematology·2004
Same author

Contact-mediated inhibition of human haematopoietic progenitor cell proliferation may be conferred by stem cell antigen, CD34.

The hematology journal : the official journal of the European Haematology Association·2002

Area of Science:

  • Hematology
  • Stem Cell Biology
  • Cellular Assays

Background:

  • Human hematopoietic stem cells (HSCs) are essential for blood cell production but are rare within the total hematopoietic cell population.
  • Mature blood cells arise from HSCs differentiating along myeloid, erythroid, and megakaryocytic lineages.
  • While assays for lineage-committed cells exist, a universally accepted assay for self-renewing pluripotent HSCs is lacking.

Purpose of the Study:

  • To review and categorize existing assay systems for human hematopoietic stem cells.
  • To highlight the importance of these assays in understanding HSC proliferation and differentiation.
  • To provide insights into quantifying and identifying human HSCs.

Main Methods:

  • Categorization of assay systems into three main classes: direct clonogenic assays, assays detecting non-clonogenic cells via progeny, and transplantation into severe combined immunodeficient (SCID) mice.

Related Experiment Videos

  • Review of in vitro and in vivo methodologies for assessing early hematopoietic cells.
  • Analysis of the utility of different assay systems for studying HSC regulation.

    • Main Results:

    • Several in vitro and in vivo assay systems have been developed for early human hematopoietic cells.
    • These systems include direct clonogenic assays, indirect detection methods, and SCID mouse xenotransplantation models.
    • Each assay type offers unique advantages for investigating HSC behavior and characteristics.

    Conclusions:

    • Diverse assay systems are available for studying human hematopoietic stem cells, despite the absence of a single universally accepted method.
    • These assays are critical for unraveling the complex regulation of hematopoiesis and for characterizing HSC populations.
    • Continued development and application of these assay systems are vital for advancing stem cell research and regenerative medicine.